The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Time without symptoms or toxicity (TWiST) in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib or placebo plus bevacizumab: Analysis of PAOLA-1/ENGOT-ov25 phase III trial.
 
Florence Joly
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; BMS; GlaxoSmithKline; Ipsen; Janssen
 
Sylvie Chabaud
No Relationships to Disclose
 
Claire Cropet
No Relationships to Disclose
 
Amélie Anota
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Ipsen; Sandoz
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Martin Demarchi
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Mundipharma
 
Beyhan Atasevan
Honoraria - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - GlaxoSmithKline; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Roche
 
Carmen Pisano
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - AstraZeneca/Merck; GlaxoSmithKline; PharmaMar
 
Nuria Lainez
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Pfizer; Roche; Sanofi
 
Irina Tsibulak
No Relationships to Disclose
 
Kan Yonemori
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Eisai; Fujifilm; Lilly Japan; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Chugai Pharma; Eisai; Novartis; OncXerna Therapeutics; Ono Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Eisai (Inst); Genmab (Inst); Haihe Pharmaceutical (Inst); Kyowa Hakko Kirrin (Inst); Lilly (Inst); MSD (Inst); Nihonkayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
 
Ignace Vergote
Consulting or Advisory Role - Agenus; Akesobio - China; Amgen (Inst); AstraZeneca; Britol Myers Squibb; Carrick Therapeutics (Inst); Clovis Oncology (Inst); Deciphera (Inst); Eisai; Elevar Therapeutics; Genmab (Inst); GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Mersana; Millennium (Inst); MSD; Novartis; Novocure; Octimet (Inst); Oncoinvent; Roche; Seagen; Sotio; Verastem (Inst); Zentalis
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro
 
Maria Lapresa
Honoraria - GlaxoSmithKline
 
Mansoor Raza Mirza
No Relationships to Disclose
 
Cecile Guillemet
No Relationships to Disclose
 
Alexander Burges
Honoraria - AstraZeneca; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Roche; Tesaro
 
Giovanni Scambia
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Speakers' Bureau - Clovis Oncology; MSD
 
Eugenia Ortega Izquierdo
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline
Travel, Accommodations, Expenses - MSD
 
Eric Pujade-Lauraine
Employment - Arcagy-Gineco
Honoraria - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Incyte; Merck; Roche
Research Funding - AstraZeneca (Inst)
Other Relationship - Arcagy-Gineco
 
Jean Emmanuel Kurtz
Employment - MSD (I)
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline
Travel, Accommodations, Expenses - Clovis Oncology; GlaxoSmithKline
 
Isabelle Laure Ray-Coquard
Honoraria - Abbvie; Advaxis; AGENUS; Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; DECIPHERA; Genmab; GlaxoSmithKline; Macrogenics; MERSANA; MSD Oncology; Novartis; OxOnc; Pfizer; PharmaMar; Roche; Seagen; Sutro Biopharma; Tesaro
Consulting or Advisory Role - Abbvie; AGENUS; AstraZeneca; BMS; Bristol-Myers Squibb; Clovis Oncology; Deciphera; Genmab; GlaxoSmithKline; Macrogenics; Mersana; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Roche; Seagen; Tesaro
Research Funding - BMS; MSD Oncology; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; BMS; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; Belgium health authorities; French National Cancer Institute (INCA); GERMAN health authorities; ITALIAN HEALTH AUTORITIES